HDCN-- Weekly Update

H: Pathophysiology -- Sympathetic nervous system
Targetting Cellular Hypoxia Alleviates Renal Neurogenic Hypertension.

Basic hemodialysis -- Complications (acute)
Effect of Eplerenone on Blood Pressure and the Renin-Angiotensin-Aldosterone System in Oligo-Anuric Hemodialysis Patients.
CRF: Problem Areas -- Outcomes (Morbidity, Mortality)
Fibroblast Growth Factor-23 and the Risk of Death and Cardiovascular Events among Patients with Chronic Kidney Disease.
Association of Serum Alkaline Phosphatase Levels with Mortality in Non- Dialysis Dependent Chronic Kidney Disease.
CRF: Problem areas -- Pre-ESRD care, initiation of dialysis
The Influence of Aging on the Progression of Chronic Kidney Disease.
Frailty and Chronic Kidney Disease: The Third National Health and Nutrition Evaluation Survey.
CRF by problem area -- Progression
FGF-23 as a Predictor of Renal Outcome in Diabetic Nephropathy.
CRF by problem area -- Bone disease/Ca-P/PTH
Fractional Excretion of Phosphorus (FEPi) Is a Useful Tool for the Assessment of Dietary Phosphate Compliance in Pre-Dialysis CKD.
Estimation of Dietary Protein Intake Is Critical to Understanding Phosphorus Balance in Chronic Hemodialysis Patients: Utility of Normalized Protein Catabolic Rate.
Low Dose (500 mg) Once Daily Wax Matrix Extended-Release Niacin Lowers Serum Phosphorus in Hemodialysis Patients.
Fermagate (Alpharen) Long-Term Use Indicates Effective Control of Serum Phosphate Combined with Good Tolerability.
Phosphate Binding Efficacy of Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients.
The Intestinal Phosphate Transporter, Npt2b Is an Important Regulator of Phosphate Homeostasis under Normal and Uremic Settings.
Switch from Low Flux Hemodialysis to Post Dilutional On-Line Haemodiafiltration: Effects on Serum Calcium, Phosphate and Parathyroid Hormone in Uraemic Patients.
Fibroblast Growth Factor-23 and Progression to Dialysis in Patients with Advanced Kidney Disease.
FGF-23 in Early CKD/Evidence in Favor of a Phosphate_Centric Paradigm for the Pathogenesis of Secondary Hyperparathyroidism.
FGF-23 Levels Predict Response to Treatment of Secondary Hyperparathyroidism.
High Intensity Focused Ultrasound: A Novel Non-Invasive Treatment for Hyperparathyroidism.
Variability of PTH Estimation in HD Patients: What Is the Potential Impact?
TACE Inhibition: A Novel Strategy for the Prevention and Treatment of Secondary Hyperparathyroidism.
Cinacalcet Pulse Therapy in Hemodialysis (HD) Patients with Overcontrolled Secondary Hyperparathyroidism (HPT) Free of Vitamin D Deficiency.
CRF by organ system -- Cardiovascular/Hypertension
Farnesyl Transferase Inhibitors Prevent Vascular Calcification.
Left Ventricular Mass Reduction in Haemodialysis Patients with Cinacalcet Therapy: Results from an Open-Label Randomised Pilot Study.

Cystic disease -- Hereditary polycystic disease
A Third Locus for Autosomal Dominant Polycystic Liver Disease.
Renal Ultrasonographic Diagnosis of Autosomal Dominant Polycystic Kidney Disease in Children.
Salt Intake Contributes to the Progression of ADPKD.
TEMPO 3/4: A Phase 3 Multicenter Trial of Tolvaptan in Adult Subjects with ADPKD.
Transplant -- Transplantation
Suboptimal Mycophenolate Mofetil Dosing Increases the Risk of Rejection in Pediatric Renal Transplant Patients on Steroid-Free Immunosuppression.
Belatacept Demonstrates Superior Composite Patient/Graft Survival in Diabetic Kidney Transplant Recipients vs CsA: Results from BENEFIT & BENEFIT -EXT.
EC-MPS Is Associated with Superior Efficacy Outcomes Compared to MMF in De Novo Kidney Transplant Patients: A Pooled Analysis.
CO Prevents Mitochondrial Damage and Apoptosis during Renal Warm Ischemia and Subsequent Cold Storage and Improves Renal Function in a Model of NHBD Kidney Transplant.
An Integrative Approach for the Transplantation of High-Risk Sensitized Patients.

RW09 Selected Abstract Cumulative List

HDCN home /about our site / subscribe to key zone / register for free zone
update email address / subscription status / forget your password?